| Owner | Title | From | %Ownership |
|---|---|---|---|
| Gadicke, Ansbert, S | Partner | 12/2018 | 25-50% |
| MPM Founders LLC | Partner | 12/2018 | 10-25% |
| Evnin, Luke, Basil | Member | 11/2015 | 50-75% |
| Gadicke 2012 Irrevocable Trust | Member | 11/2015 | 25-50% |
| Bardon, Christiana, Goh | Trustee | 11/2015 | |
| Gadicke, Ansbert, S | Trustee | 01/2012 | |
| Karger, Paul | Trustee | 01/2015 | |
| Gadicke, Ansbert, S | Trustee | 01/2015 | |
| Karger, Paul | Trustee | 01/2015 | |
| Laguerre, Kristen, Lee | Chief Financial Officer and Chief Operations Officer | 10/2019 | < 5% |
| Mcgrath, Nicholas, Myles | General Counsel and Chief Compliance Officer | 06/2019 | < 5% |
| Acg Investment Holdings, LLC | Partner | 12/2018 | 5-10% |
| Acg Investment Holdings Series #1 | Partner | 12/2018 | 10-25% |
| Ansbert K. Gadicke 2015 Irrevocable Trust II | Member | 05/2019 | > 75% |
| Christiana G. Bardon 2015 Irrevocable Trust II | Member | 05/2019 | > 75% |
| Ansbert K. Gadicke 2015 Irrevocable Trust II | Member | 11/2015 | 25-50% |
| Fund structure | AUM | Fund type |
|---|---|---|
| MPM Oncology Impact Management, L.P. | $1.19 bn | |
| Ubs Oncology Impact Fund L.P. | $1.19 bn | Other Private Fund |
| Ubs Oncology Impact Fund (Cayman) Investor LTD. | ||
| Ubs Oncology Impact Fund (Cayman) Investor L.P. |
